J 2014

Odor Identification in Frontotemporal Lobar Degeneration Subtypes

MAGEROVA, Hana, Martin VYHNALEK, Jan LACZO, Ross ANDEL, Irena REKTOROVÁ et. al.

Basic information

Original name

Odor Identification in Frontotemporal Lobar Degeneration Subtypes

Authors

MAGEROVA, Hana (203 Czech Republic), Martin VYHNALEK (203 Czech Republic), Jan LACZO (203 Czech Republic), Ross ANDEL (840 United States of America), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), Alexandra KADLECOVA (203 Czech Republic), Martin BOJAR (203 Czech Republic) and Jakub HORT (203 Czech Republic)

Edition

American Journal of Alzheimer's Disease and other Dementias, Thousand Oaks, SAGE Publications Inc. 2014, 1533-3175

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.627

RIV identification code

RIV/00216224:14110/14:00078744

Organization unit

Faculty of Medicine

UT WoS

000345335300017

Keywords in English

odor identification; behavioral variant frontotemporal dementia; primary nonfluent aphasia; semantic dementia; progressive supranuclear palsy; cognitive status

Tags

Tags

International impact, Reviewed
Změněno: 27/1/2015 18:35, Soňa Böhmová

Abstract

V originále

Odor identification impairment is a feature of several neurodegenerative disorders. Although neurodegenerative changes in the frontotemporal lobar degeneration (FTLD) subtypes involve areas important for olfactory processing, data on olfactory function in these patients are limited. An 18-item, multiple-choice odor identification test developed at our memory clinic, the Motol Hospital smell test, was administered to 9 patients with behavioral variant frontotemporal dementia, 13 patients with the language variants, primary nonfluent aphasia (n = 7) and semantic dementia (n = 6), and 8 patients with progressive supranuclear palsy. Compared to the control group (n = 15), all FTLD subgroups showed significant impairment of odor identification (P < .05). The differences between the FTLD subgroups were not significant. No correlation between odor identification and neuropsychological tests results was found. Our data suggest that odor identification impairment is a symptom common to FTLD syndromes, and it seems to be based on olfactory structure damage rather than cognitive decline.